Non-invasive and quantifiable diagnosis of Parkinson’s disease is an ongoing challenge for researchers. In this study, we worked on the CEST signal at 2ppm (CEST@2ppm) in the substantia nigra of acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse models at three different time points including pre and 3rd day, 10th day after treatment. CEST@2ppm after 5-pool lorentzian fitting showed a statistically significant difference after MPTP injection and metrics based on this fitting model ( MTRrex and AREX) also indicated positive correlation of CEST@2ppm with the SN damages while the statistic difference of 3rd and 10th day was not significant. This quantifying CEST signal may reflect the pathological mechanism of PD in SN.
This abstract and the presentation materials are available to members only; a login is required.